International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 105-111 doi: 10.5281/zenodo.16417464
Original Article
A Study Of Comparison Of Conventional Tests With Cbnaat In Diagnosis Of Tuberculosis In Patients With Ascites And Cirrhosis Of Liver And Their Clinico-Laboratory Profile
 ,
 ,
Published
July 25, 2025
Abstract

BACKGROUND AND OBJECTIVES: Tuberculosis remains a major health problem, with an estimated 9.6 million deaths every year worldwide  and approximately 1.5 million cases in india , currently on treatment. Diagnosis of extra pulmonary tuberculosis( EPTB) particularly tubercular ascites with lymphocytic predominance remained challenging over decades due to paucibacillary nature of ascitic fluid. The lack of explicit clinical features ascertaining the tubercular infection in cases of cirrhosis of liver, delays diagnosis and treatment of the tuberculosis leading to high mortality rate. The conventional diagnostic methods such as cytology, ADA, ZN staining and LJ culture done from ascitic fluid are not very sensitive for diagnosis of tuberculosis in ascites. Liquid culture methods adopted by most countries in the last ten years have improved the sensitivity to some extent but are time consuming, expensive and need sophisticated laboratory infrastructure. Detection of tuberculosis by CBNAAT in ascitic fluid has improved the sensitivity and specificity, especially when organisms are present in very small amounts. The objective is to diagnose secondary abdominal tuberculosis in patients with cirrhosis of liver and to compare conventional lab parameters with CBNAAT.

MATERIALS AND METHODOLOGY: Observational study of 50 patients attending a tertiary care hospital

Inclusion criteria:

  • Adults > 19 years and willing to give informed consent
  • Ascites due to cirrhosis of liver.

Exclusion criteria:

  • Adults with Ascites due to other causes like Nephrotic syndrome, CCF, Hypoproteinemia, Pancreatitis.

       ·  Primary abdominal tuberculosis

Patients were examined, investigated and evaluated for abdominal tuberculosis. Investigations included:

 1. Ascitic fluid analysis for cell count, cell type, gram’s stain, ZN stain for AFB, sugars, proteins, LDH, ADA, CBNAAT and culture.

2. USG abdomen.

 3. CBC, LFT, PT, APTT, INR.

 

Collected data was entered into MS excel sheet and was analyzed using software version 24. Data was expressed as descriptive statistics using frequency and percentage. Comparison between the tests was done using chi-square test, p value<0.05 was considered significant and diagnostic accuracy of CBNAAT test was Observed.

 

RESULTS: Among the 50 cases with liver cirrhosis taken for the study, 7 were CBNAAT TB positive, 2 were AFB positive and 3 were ADA positive. Based on the study conducted, CBNAAT showed significant difference in diagnosis of TB compared to AFB and ADA. CBNAAT was able to detect significantly a greater number of abdominal TB compared to AFB and ADA (p<0.05)

CONCLUSION: The outcome of the present study concludes that CBNAAT has a definite role in the diagnosis of tuberculosis. CBNAAT should be routinely utilized for rapid diagnosis of EPTB along with other conventional methods like AFB smear examination, ADA and culture for better overall results in the diagnosis of EPTB.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
377 Views
317 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved